Streptococci Lecture 5 - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Streptococci Lecture 5

Description:

Streptococci Lecture 5 Medical Microbiology SBM 2044 Group A Streptococci Encounter Carriers appear asymptomatic Person-to-person spread is mediated by respiratory ... – PowerPoint PPT presentation

Number of Views:124
Avg rating:3.0/5.0
Slides: 28
Provided by: sayap
Category:

less

Transcript and Presenter's Notes

Title: Streptococci Lecture 5


1
StreptococciLecture 5
  • Medical Microbiology
  • SBM 2044

2
Streptococcus
  • Gram-positive
  • Grow in chains
  • Non-motile
  • Facultative anaerobes
  • 3 types of streptococci classification
  • Early studies distinguished 3 broad groups on
    blood agar
  • Group-specific antigens (Lancefield
    classification) by serological reactivity of
    extracted cell wall antigens (A ? U)
  • Species biochemical tests

3
(No Transcript)
4
Streptococcus pyogenes
  • Natural habitat Humans
  • Strains distinguished by M serotyping
  • Devised by Lancefield in 1920s, using panels of
    absorbed sera
  • to hot-HCl extracted antigen, she called M
    antigen
  • gt 100 distinct M types of GAS distinguished
    since then
  • - called M1, M2, M3, M4,..etc.
  • Highly versatile pathogen
  • Suppurative infections
  • Toxinogenic diseases
  • Immunologically-mediated diseases

5
  • GAS diseases changing patterns
  • Changes in virulence of prevailing GAS strains ?
  • Changes in social conditions less crowding?
  • Reemergence of severe invasive infections
  • Sporadic cases since mid-1980s new virulent
    strains?
  • Streptococcal toxic shock
  • Some cases associated with obviously severe
    tissue infections
  • Many others shock following mild or
    unapparent infections
  • Sporadic implies predisposing factors

6
Group A Streptococci
Principle sites of infection
Invasive infections
Local spread (e.g.)
Other tissues
Pharyngitis, tonsillitis, otitis media, sinusitis.
Pharynx
Bacteraemia or septicaemia
Skin pyroderma, erysipelas
Occasionally
Streptococcal Toxic Shock
Extensive necrosis (necrotizing fasciitis)
Deep-seated tissues
  • Puerperal fever (childbirth fever) in women
    major killer in past

7
Streptococcus pyogenes
Tonsillitis
Follicular tonsillitis
8
Streptococcus pyogenes
Impetigo
Erysipleas
Cellulitis
9
Streptococcus pyogenes
Necrotizing fasciitis
(lt 24 hours post surgery)
10
Streptococcus pyogenes
Scarlet fever
11
Group A Streptococci
  • Encounter
  • Carriers appear asymptomatic
  • Person-to-person spread is mediated by
    respiratory droplets or by direct contact to skin
  • Entry
  • For pyodermal infections, streptococci need to
    gain entry into deeper layers of skin
  • In pharyngeal infections, to prevent from being
    swept away, GAS must adhere to lipoteichoic acid
    (LTA), protein F and/or M protein

12
M protein
  • Important for cell adherence to keratinocytes
  • Prevent opsonization by complement
  • bind to fibrinogen and interferes with the
    alternative pathway
  • bind with host complement control proteins and
    inhibit opsonins formation
  • Hypervariable regions of M protein are antigenic,
    but there are gt 100 M protein serotypes

13
EM showing the M Proteins (hair-like surface
structures) of S. pyogenes
14
Group A Streptococci
  • Spread and multiplication
  • Most GAS remain localised to the site of initial
    infection
  • In pharynx and tonsils, may result in erythema
    and exudate associated with strep throat
  • Peritonsillar abscess (quinsy) or spread to
    adjacent structures (mastoid and middle ear)
  • Impetigo in skin
  • Erysipelas and cellulitis in deeper layers of
    skin
  • GAS may spread laterally in deep tissues, by
    secreting enzymes
  • necrotizing fasciitis and myositis

15
GAS virulence factors Excreted products
  • Cytolytic toxins
  • Streptolyxin O (SLO)

Produced by all strains
  • Streptolysin S (SLS)
  • Various subtle effects at sub-lytic
    concentrations
  • SLO sensitive to O2
  • SLS stable in O2

b-haemolysis
Thiol-activated toxin
16
SLO- and SLS-defective mutants
  • murine s.c. model - weight loss at 24h post
    infection

Sterile
3 x 108 cfu
3 x 106 cfu
0.5
3 x 107 cfu
3 x 109 cfu
3 x 105 cfu
0.0
- 0.5
- 1.0
Weight gain (grams)
- 1.5
- 2.0
- 2.5
slo?1- sagB?1
sagB?1
WT
slo?1
PBS
17
Hyaluronic acid capsule
  • Antiphagocytic structure on bacterial surface
  • Hyaluronic acid is abundant in human connective
    tissue - hence GAS can camouflaged themselves
  • But capsule may interfere with the adherence of
    GAS to epithelial cells
  • so GAS shed the capsule during the early stages
    of infection using hyaluronidase

18
Secreted protein Function
Proteases
Hyaluronidase spreading factor
Streptolysins S and O form pores in the host membranes
Deoxyribonucleases (DNase)
Streptokinase bind to human protein plasminogen, and convert this to plasmin plasmin degrades fibrin
19
Damage
  • GAS can evoke an intense inflammatory responses
    in tissues
  • Streptococcal pyrogenic exotoxins (SPE)
  • SPE A, B and C cause rash, a characteristic of
    scarlet fever
  • SPE A and C are bacterial superantigens that
    activate a large subset of T cells
  • Immunologically mediated disease (nonsuppurative
    sequelae)
  • acute rheumatic fever (ARF)
  • acute post-streptococcal glomerulonephritis

20
Toxic Shock
  • In past probably linked to scarlet fever
  • Since mid-1980s associated with new highly
    virulent
  • strains - rapidly fulminating
  • some cases in previously healthy young adults,
    no obvious
  • predisposing factors
  • Associated with production of superantigenic
    toxins, but
  • other factors also involved

21
Acute rheumatic fever (ARF)
  • autoimmune disease - triggered only by GAS
    pharyngitis
  • associated with strong immune response to GAS.
  • antibodies and/or T cells X-react with host
    antigens? (later)
  • Symptoms arise gt 10days after GAS infection
  • responsible GAS strain already cleared
  • Symptoms may include
  • inflammation multiple sites, starting with major
    joints (arthritis)
  • neurological disorders (Sydenhams chorea)
  • rheumatic heart disease (RHD) (ca 50 cases)
  • - damage to heart valves, permanent scaring
    in survivors

22
Acute rheumatic fever (ARF)
  • Initial attack rates low (3 in untreated
    pharyngitis)
  • High recurrence (up to 50) - increasing in
    severity

Widespread prescription of penicillin for sore
throats
Remarkably, GAS have not (yet ?) developed
resistance to penicillins
23
GAS infections - complications
Post-streptococcal acute glomerulonephritis
(PSGN)
  • Common, but rarely life-treating - some GAS
    infections
  • of either pharynx or skin.
  • Symptoms arise some 10 days after infection
  • reflect kidney dysfunction, probably involving
    inflammation
  • of glomeruli
  • Pathogenesis
  • Most probably entrapment of GAS antigen-host
    antibody
  • complexes at basement membranes of glomeruli
  • might also involve an autoimmune response

24
Normal glomerulus
Glomerulonephritis
Mesangial cell
Mesangial cell intrusion
Endothelial cell, has
100 nm pores
PMN
Basement membrane
Inflammation
Too much large immune complex entrapment ?
Small complexes diffuse thro basement membrane
into urine, but the occasional larger
complex cant is normally removed by mesangial
cell
Example Sequel of some
S. pyogenes infections
25
Treatment and Prevention
  • Penicillin 10 day oral therapy
  • Erythromycin or other macrolide antibiotics for
    individuals allergic to penicillin

26
Group B streptococci
  • Streptococcus agalactiae are aerobic G
    diplococci that are ß-haemolytic on blood agar
    plates
  • found in lower GIT and female genital tracts
  • GBS is a leading cause of neonatal sepsis and
    meningitis
  • prevent opsonization and phagocytosis with a
    polysaccharide capsule

27
Enterococci
  • Enterococcus faecalis cause UTI, wound
    infections, endocarditis, intraabdominal
    abscesses and bacteremia.
  • Normal flora of GIT and GUT
  • resistant to bile and high salt concentrations
  • nosocomial infections
  • resistance to many antibiotics, often
    bacteriostatic
  • bacterial killing must use a combination
    treatment of a ß-lactam and an aminoglycoside
Write a Comment
User Comments (0)
About PowerShow.com